Researchers had every reason to expect that a compound called BKM120 (also known as buparlisib) would stifle glioblastoma brain tumors lacking the protein PTEN. After all, it was known to block the tumor-promoting PI3K protein and could easily pass through the blood-brain barrier — the dense layer of cells that guards entry to the brain … Continued
Charlie Benoit was told that he had a long road ahead of him when he was diagnosed with glioblastoma in 2011. More than seven years later, he’s still doing well—and by studying patients like Benoit, researchers hope to help other patients with this incurable form of brain cancer. In 2011, Benoit, then 48, was getting … Continued
Brain tumors are graded on a scale of 1 to 4, based on how malignant, or cancerous, they are, in an effort to anticipate the tumor’s likely growth rate. A grade of 1 is the least malignant, and is considered low-grade, while 4 is the most malignant and considered high-grade.
Upon learning she had brain cancer in early 2016, Connie Etheridge immediately thought, “Thank goodness it’s me, and not my children.” Then, three months later, her son Trevor, 23, found out he too had brain cancer. It was a devastating double diagnosis, but the Etheridges have been by each other’s side through check-ups, radiation, and … Continued
It’s 19 months after being diagnosed with the aggressive brain tumor, glioblastoma, and Andrew Wall is itching to go back to work as a police officer. “Sitting around is not my thing,” says Wall, 53, who hasn’t yet been cleared to return to work as a police officer in Monroe, Connecticut – a job he has … Continued
Glioblastomas are the most common primary cancer of the brain, with 13,000 new cases being diagnosed each year in the United States. Although it is a fast-moving cancer, doctors know a lot about this type of tumor and are finding ways to fight it. Here are five things you need to know about glioblastomas. 1. … Continued
The drug Avastin, when added to initial therapy for glioblastoma, can give patients a few extra months’ reprieve before their brain tumors start growing again, but does it make their quality of life better – or worse? That’s a matter of heated debate for doctors – and confusion for patients – after two large clinical … Continued